(b)(4).Send customer to local pharmacy or place of purchase for replacement product.Customer returned a defective syringe for investigation.Qc investigation on (b)(6) 2018 resulted in defect found; bent needle observed.Final root cause: rc-003 other: improper use/ mishandled by end user based on the post market review (b)(4) and review of the fda's total product life cycle (tplc) - total device problems, for possible delay in administration of insulin.Reference - capa (b)(4).Note: manufacturer contacted customer (several attempts) in a follow-up call to ensure that the replacement products resolved the initial concern - unable to establish contact with the customer at this time.Product notification letter sent to customer to contact customer care.
|